Get the Stockscreener App
6.59
5.59%
-0.39
After Hours:
6.61
0.02
+0.30%
Recursion Pharmaceuticals Inc Stock (RXRX) Forecast
The Recursion Pharmaceuticals Inc (RXRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.285, representing a -80.50% decrease from the current price of $6.59. The highest analyst price target is $1.0587, and the lowest is $1.5113.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RXRX Price Target
Average 2.8214
(-57.19% Downside)
Is Recursion Pharmaceuticals Inc (RXRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.28 | Neutral |
| STOCH(9,6) | 43.67 | Neutral |
| STOCHRSI(14) | 11.25 | Buy |
| MACD(12,26) | -0.0312 | Buy |
| ADX(14) | 14.71 | Neutral |
| William %R | -65.99 | Neutral |
| CCI(14) | -11.69 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.855
Sell
|
6.8106
Sell
|
| MA20 |
6.571
Buy
|
6.7993
Sell
|
| MA50 |
7.0152
Sell
|
7.0804
Sell
|
| MA100 |
7.8309
Sell
|
7.6365
Sell
|
| MA200 |
9.031
Sell
|
8.1506
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, RXRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 9 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on RXRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.28 indicates that RXRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 43.67 indicates that RXRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.25 indicates that RXRX is oversold. This suggests that RXRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.71 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -11.69 indicates that RXRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RXRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Recursion Pharmaceuticals Inc financial reports and earnings history, Recursion Pharmaceuticals Inc (RXRX) stock could reach $8.5765 by 2030, $57.31 by 2040 and $101.66 by 2050. See the projected annual prices until 2050 of the Recursion Pharmaceuticals Inc stock below:
- Recursion Pharmaceuticals Inc (RXRX) is expected to reach an average price of $31.14 in 2035, with a high prediction of $31.52 and a low estimate of $31.60. This indicates an $372.58% rise from the last recorded price of $6.59.
- Recursion Pharmaceuticals Inc (RXRX) stock is projected to chart a bullish course in 2040, with an average price target of $62.31, representing an $845.52% surge from its current level. The forecast ranges from a conservative $18.76 to a sky-high $57.31.
- Our analysts predict Recursion Pharmaceuticals Inc (RXRX) to jump 741.15% by 2045, soaring from $55.56 to an average price of $55.43, potentially reaching $54.70. While $55.56 is the low estimate, the potential upside is significant.
- Recursion Pharmaceuticals Inc (RXRX) stock is expected to climb by 2050, reaching an average of $100.55, a $1,426% jump from its current level. However, a wide range of estimates exists, with high and low targets of $101.66 and $101.47, respectively, highlighting the market's uncertainty.
Recursion Pharmaceuticals Inc Stock (RXRX) Year by Year Forecast
Recursion Pharmaceuticals Inc Stock (RXRX) Price Forecast for 2024
Our forecast for RXRX stock price in 2024 now indicates an average price target of $8.0222 with a high forecast of $15.74 and a low forecast of $0.3045. The average prediction reflects an increase of +21.73% from the last recorded price of $6.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2024 | $1.1588 | $1.5113 | $1.0587 | -82.42% |
| December, 2024 | $1.3921 | $1.4346 | $1.5362 | -78.88% |
Recursion Pharmaceuticals Inc Stock (RXRX) Price Forecast for 2025
Recursion Pharmaceuticals Inc Stock (RXRX) is expected to reach an average price of $2.8214 in 2025, with a high prediction of $5.6019 and a low estimate of $0.0409. This indicates an -57.19% fall from the last recorded price of $6.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.9112 | $4.8179 | $4.8153 | -25.48% |
| February, 2025 | $5.8544 | $4.847 | $4.7644 | -11.16% |
| March, 2025 | $6.2277 | $6.0803 | $5.6019 | -5.50% |
| April, 2025 | $3.7468 | $5.261 | $5.3935 | -43.14% |
| May, 2025 | $2.1901 | $2.9001 | $2.3343 | -66.77% |
| June, 2025 | $1.0234 | $2.7984 | $2.5176 | -84.47% |
| July, 2025 | $0.4325 | $0.6325 | $2.235 | -93.44% |
| August, 2025 | $0.1942 | $0.0659 | $3.6259 | -97.05% |
| September, 2025 | $0.8609 | $0.0409 | $1.5509 | -86.94% |
| October, 2025 | $0.6982 | $0.2601 | $3.2777 | -89.41% |
| November, 2025 | $1.3114 | $1.0798 | $0.494 | -80.10% |
| December, 2025 | $0.8205 | $1.2205 | $1.7131 | -87.55% |
Recursion Pharmaceuticals Inc Stock (RXRX) Price Forecast for 2026
The predicted value for Recursion Pharmaceuticals Inc (RXRX) in 2026 is set at an average of $4.484. Estimates vary from a peak of $8.8457 to a trough of $0.1222, indicating an -31.96% surge from the present price of $6.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.0638 | $1.338 | $0.8522 | -83.86% |
| February, 2026 | $0.5571 | $1.3371 | $1.0455 | -91.55% |
| March, 2026 | $2.1504 | $2.0587 | $1.8604 | -67.37% |
| April, 2026 | $3.3895 | $2.4062 | $3.2595 | -48.57% |
| May, 2026 | $0.4372 | $0.1222 | $2.5803 | -93.37% |
| June, 2026 | $0.756 | $0.1686 | $2.2748 | -88.53% |
| July, 2026 | $5.2749 | $0.9019 | $8.8457 | -19.96% |
| August, 2026 | $0.9516 | $0.7916 | $6.559 | -85.56% |
| September, 2026 | $1.2125 | $0.5183 | $2.3158 | -81.60% |
| October, 2026 | $0.7608 | $0.2908 | $1.5467 | -88.46% |
| November, 2026 | $1.0141 | $1.2716 | $1.5983 | -84.61% |
| December, 2026 | $0.7368 | $0.1532 | $1.0926 | -88.82% |
Recursion Pharmaceuticals Inc Stock (RXRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Recursion Pharmaceuticals Inc (RXRX) is $6.0318, with a high forecast of $11.66 and a low forecast of $0.401. This indicates an -8.47% decrease from the last price of $6.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.4235 | $0.401 | $4.7335 | -48.05% |
| February, 2027 | $3.5603 | $2.8727 | $7.8519 | -45.97% |
| March, 2027 | $7.4211 | $2.6178 | $9.3761 | +12.61% |
| April, 2027 | $5.4879 | $4.4279 | $9.8453 | -16.72% |
| May, 2027 | $2.8946 | $2.7996 | $6.667 | -56.08% |
| June, 2027 | $5.79 | $1.6738 | $3.4513 | -12.14% |
| July, 2027 | $0.8166 | $3.7666 | $5.4216 | -87.61% |
| August, 2027 | $4.3731 | $1.7982 | $1.7502 | -33.64% |
| September, 2027 | $7.6613 | $6.6248 | $7.2613 | +16.26% |
| October, 2027 | $7.5079 | $8.203 | $6.6779 | +13.93% |
| November, 2027 | $7.8244 | $7.8145 | $6.9122 | +18.73% |
| December, 2027 | $14.19 | $9.3161 | $11.66 | +115.37% |
Recursion Pharmaceuticals Inc Stock (RXRX) Price Forecast for 2028
In 2028, Recursion Pharmaceuticals Inc (RXRX) is projected to reach an average price of $13.60, with a high projection of $17.29 and a low estimate of $9.9147. This indicates an +106.44% rise from the last price of $6.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $13.02 | $13.94 | $13.37 | +97.56% |
| February, 2028 | $16.93 | $14.20 | $13.93 | +156.84% |
| March, 2028 | $16.34 | $16.86 | $16.94 | +148.01% |
| April, 2028 | $17.40 | $17.32 | $16.80 | +164.04% |
| May, 2028 | $16.94 | $17.18 | $17.29 | +157.04% |
| June, 2028 | $13.64 | $14.82 | $15.62 | +106.91% |
| July, 2028 | $13.69 | $14.05 | $13.54 | +107.77% |
| August, 2028 | $11.85 | $12.22 | $13.51 | +79.82% |
| September, 2028 | $7.9466 | $10.89 | $10.74 | +20.59% |
| October, 2028 | $10.00 | $10.25 | $9.4999 | +51.79% |
| November, 2028 | $10.60 | $9.9147 | $9.3765 | +60.87% |
| December, 2028 | $10.41 | $10.83 | $10.40 | +57.94% |
Recursion Pharmaceuticals Inc Stock (RXRX) Price Forecast for 2029
The 2029 price forecast for Recursion Pharmaceuticals Inc Stock (RXRX) is $7.1504 on average, with a high prediction of $11.81 and a low estimate of $2.4919. This represents an +8.50% increase from the previous price of $6.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.56 | $10.93 | $11.35 | +75.36% |
| February, 2029 | $10.29 | $10.69 | $11.27 | +56.19% |
| March, 2029 | $10.41 | $10.65 | $10.21 | +57.96% |
| April, 2029 | $10.90 | $10.37 | $10.19 | +65.34% |
| May, 2029 | $11.48 | $10.99 | $10.68 | +74.26% |
| June, 2029 | $11.70 | $11.92 | $11.81 | +77.55% |
| July, 2029 | $8.3272 | $8.2105 | $10.29 | +26.36% |
| August, 2029 | $9.1554 | $7.5204 | $8.4554 | +38.93% |
| September, 2029 | $1.4619 | $2.4919 | $1.2319 | -77.82% |
| October, 2029 | $6.3401 | $3.5036 | $5.8702 | -3.79% |
| November, 2029 | $6.6867 | $6.1418 | $5.82 | +1.47% |
| December, 2029 | $8.2033 | $6.9583 | $7.4533 | +24.48% |
Recursion Pharmaceuticals Inc Stock (RXRX) Price Forecast for 2030
Recursion Pharmaceuticals Inc Stock (RXRX) is expected to reach an average price of $10.49 in 2030, with a high forecast of $20.69 and a low forecast of $0.2957. This signifies an +59.20% surge from the last price of $6.59.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.5815 | $8.4165 | $8.5765 | -0.13% |
| February, 2030 | $5.598 | $6.198 | $6.2931 | -15.05% |
| March, 2030 | $0.8346 | $3.2629 | $3.1847 | -87.34% |
| April, 2030 | $2.9211 | $2.1462 | $1.5579 | -55.67% |
| May, 2030 | $1.6707 | $0.2957 | $3.9507 | -74.65% |
| June, 2030 | $0.8659 | $0.8326 | $1.949 | -86.86% |
| July, 2030 | $2.6941 | $1.3075 | $2.5441 | -59.12% |
| August, 2030 | $22.38 | $2.8674 | $19.50 | +239.57% |
| September, 2030 | $13.29 | $15.66 | $18.95 | +101.63% |
| October, 2030 | $22.05 | $17.65 | $17.37 | +234.67% |
| November, 2030 | $20.89 | $21.57 | $20.69 | +217.06% |
| December, 2030 | $20.34 | $20.97 | $19.89 | +208.71% |
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):